Results 201 to 210 of about 1,301,845 (266)

Late effects

open access: yesРоссийский журнал детской гематологии и онкологии, 2016
openaire   +1 more source

Liquid biopsy‐based diagnostic evaluation of hypermethylated CpG sites for ovarian cancer diagnosis

open access: yesMolecular Oncology, EarlyView.
This schematic outlines the workflow from biomarker identification to duplex MethyLight assay validation for epithelial ovarian cancer diagnosis using cfDNA‐based liquid biopsy. Initial screening of hypermethylated CpG candidates (cg02957270, cg10061138 cg00480298, COL2A1) was performed in tissue using ARMS‐PCR, COBRA, qPCR and image analysis. Selected
Deepa Bisht   +3 more
wiley   +1 more source

Outcomes of a Formal Hematopoietic Cell Transplantation Survivorship Program on Screening for Late Effects. [PDF]

open access: yesTransplant Cell Ther
Newcomb RA   +13 more
europepmc   +1 more source

PAK1 activation drives divergent resistance mechanisms to aromatase inhibition and tamoxifen in a luminal: A breast cancer model

open access: yesMolecular Oncology, EarlyView.
Breast cancer remains a major cause of cancer death in women, frequently developing endocrine therapy resistance. This study demonstrates that upregulated p21‐activated kinase 1 (PAK1) activity drives resistance to tamoxifen and long‐term estrogen deprivation in ER+ breast cancer models.
Luisa Schwarzmüller   +10 more
wiley   +1 more source

Health-Related Quality of Life in Danish Cancer Survivors Referred to a Late Effects Clinic: A Prospective Cohort Study. [PDF]

open access: yesActa Oncol
Tolstrup LK   +6 more
europepmc   +1 more source

Illuminating the hidden cost: A systematic review of cognitive late effects regarding cancer-related fatigue in treated paediatric brain tumors. [PDF]

open access: yesTech Innov Patient Support Radiat Oncol
Vethe Hernes I   +3 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Radiotherapy and Late Effects

Pediatric Clinics of North America, 2020
Advances in multimodality care for patients with pediatric cancer continues to improve long-term survival. The use of surgery, chemotherapy, and radiotherapy may lead to debilitating late effects in childhood cancer survivors. It is critically important to understand, mitigate, and screen for late effects to improve the quality of life in childhood ...
Joshua D, Palmer   +5 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy